Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78
NHI (NHI) Q2 2026 Earnings Call Transcript
National Health Investors Inc (NHI) (Q2 2026) Earnings Call Highlights: Strategic Pivot to SHOP ...
National Health Investors Q2 Earnings Call Highlights
National Health Investors, Inc. 2026 Q2 - Results - Earnings Call Presentation
National Health Investors, Inc. (NHI) Q2 2026 Earnings Call Transcript
National Health Investors, Inc. Q2 2026 Earnings Call Summary
NHI Issues Investor Update
NHI Announces Second Quarter 2026 Results
National Health Investors Affirms FY2026 FFO Guidance of $4.74-$4.79 vs $4.84 Est
National Health Investors Q2 FFO $1.19 Misses $1.26 Estimate, Sales $121.319M Beat $111.677M Estimate
National Health Investors (NHI) Could Be 12% Undervalued As New COO Draws Fresh Interest
NHI Appoints Chris Maingot as Chief Operating Officer
National Health Investors Adds Former Longview CEO Chris Maingot As COO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81
National Health Investors: An Investment-Grade Healthcare REIT With Portfolio Growth And More
National Health Investors Clears HSR Review For Sale Of 35 Senior Housing And Skilled Nursing Properties, Closing Expected July 1
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.